Business Context and Reporting Period
This Form 8-K is a current report filed by Tivic Health Systems, Inc. (not Valion Bio, Inc.) on August 9, 2024. The filing documents the results of the Company's 2024 Annual Meeting of Stockholders held on that date and the adoption of an amended equity incentive plan.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metric.
Material Changes and Corporate Actions
- Equity Plan Amendment: The Company adopted its Amended and Restated 2021 Equity Incentive Plan. Key changes include increasing the authorized share pool from 92,376 to 1,000,000 shares and removing limitations on incentive stock option exercises, vesting periods, and non-employee director compensation.
- Shareholder Participation: As of the record date (June 17, 2024), there were 6,183,592 shares outstanding. Approximately 38.7% (2,395,964 shares) were represented at the meeting, establishing a quorum.
- Director Elections: Stockholders elected Jennifer Ernst and Sheryle Bolton as Class III directors.
- Accounting Firm Ratification: Stockholders ratified the selection of Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
Voting Results and Management Commentary
All four proposals presented at the Annual Meeting were approved by the stockholders. Notably, while Proposal No. 4 (adjournment to solicit additional proxies) was approved, the chair did not elect to adjourn the meeting as all other proposals had already passed.
| Proposal | Votes For | Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|---|
| Election of Directors (Jennifer Ernst) | 654,527 | 149,582 | - | 1,591,855 |
| Election of Directors (Sheryle Bolton) | 596,810 | 207,299 | - | 1,591,855 |
| Adoption of A&R Equity Plan | 581,820 | 215,605 | 6,684 | 1,591,855 |
| Ratification of Auditors | 2,241,997 | 153,663 | 304 | - |
| Adjournment Proposal | 1,993,342 | 390,670 | 11,952 | - |
Investor Verification Checklist
- Verify the correct registrant name is Tivic Health Systems, Inc. (Ticker: TIVC), as the input metadata incorrectly referenced "Valion Bio, Inc."
- Review the full text of the Amended and Restated 2021 Equity Incentive Plan (Exhibit 10.1) to understand the specific terms of the increased share pool and removed restrictions.
- Confirm the impact of the 1,000,000 share increase on potential future dilution relative to the 6,183,592 shares outstanding.
- Check the Definitive Proxy Statement (Schedule 14A) filed on June 28, 2024, for detailed background on the director nominees and the equity plan rationale.